From Domanivka – in the Mykolaiv region in the south of Ukraine, which serves three territorial communities – getting to a hospital in a larger city is not simple.

There is no railway station. Bus routes are limited. For many families, travelling for a blood test or an X-ray can mean hours on the road and money they cannot spare.

For the 22,800 people living across the Domanivka, Prybuzke and Mostove communities – and more than 4,000 internally displaced people who have arrived since the full-scale invasion of Ukraine in 2022 – local healthcare is essential.

At the Domanivka hospital, new diagnostic equipment is helping doctors and nurses deliver faster, safer care, helping ensure that patients can receive essential care within their community.

The hospital is one of more than 15 healthcare facilities receiving medical equipment through a UNOPS-implemented project funded by the global healthcare company Novo Nordisk.

“The project aligns with Novo Nordisk’s purpose‑driven and patient‑centred approach, reflecting the company’s commitment to improving access to healthcare and supporting resilient health systems through trusted, responsible partnerships,” says Vladyslav Moroz, General Manager for Novo Nordisk Ukraine.

“Quality healthcare is fundamental to well-being and development, and we’re committed to improving access to essential medical services for Ukrainian communities devastated by the ongoing war,” said Tim Lardner, UNOPS Regional Director for Europe and Central Asia.

“Through this partnership, we are helping build the capacity and resilience of the healthcare system in Mykolaiv – essential for communities to recover and rebuild their lives,” he added.